Severe offtarget effects following intravenous delivery of AAV9-MECP2 in a female mouse model of Rett syndrome
Rett syndrome (RTT) is a severe X-linked neurodevelopmental disorder that is primarily caused by mutations in the methyl CpG binding protein 2 gene (MECP2). RTT is the second most prevalent genetic cause of intellectual disability in girls, and there is currently no cure for the disease. We have pre...
Main Authors: | Valerie Matagne, Emilie Borloz, Yann Ehinger, Lydia Saidi, Laurent Villard, Jean-Christophe Roux |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-02-01
|
Series: | Neurobiology of Disease |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0969996120305118 |
Similar Items
-
A codon-optimized Mecp2 transgene corrects breathing deficits and improves survival in a mouse model of Rett syndrome
by: Valerie Matagne, et al.
Published: (2017-03-01) -
Analysis of Astroglial Secretomic Profile in the Mecp2-Deficient Male Mouse Model of Rett Syndrome
by: Yann Ehinger, et al.
Published: (2021-04-01) -
Huntingtin phosphorylation governs BDNF homeostasis and improves the phenotype of Mecp2 knockout mice
by: Yann Ehinger, et al.
Published: (2020-02-01) -
Mutation analysis of the MECP2 gene in Romanian females with Rett syndrome
by: Dumitriu Simona, et al.
Published: (2013-12-01) -
Progressive Encephalopathy in Boys with Symptoms of Rett Syndrome and MECP2 Mutations
by: J Gordon Millichap
Published: (2006-08-01)